• Kidney Function Decline May Not Be Good Indicator of Trial Outcomes in Alport Syndrome Patients, Study Suggests
  • Facebook Video That Led to Mom Getting New Kidney Also Spotlights Living Donor Program
  • Early Inflammation Could Drive Both ADTKD and Alport Syndrome Kidney Disease, Study Suggests
  • Genetic Testing Could Help Doctors Make Alport Syndrome Diagnosis, Study Reports
  • Reata Starts Phase 3 Portion of Trial of Bardoxolone Methyl for Kidney Disease Due to Alport Syndrome
  • Loss of Specialized Kidney Cells Accelerated in Alport Patients, Study Shows
  • Therapy for Alport Syndrome Advancing after Stock Sale, Reata Pharmaceuticals Announces
  • Reata’s Bardoxolone for Alport Enters Phase 3 Trial After Improvements Seen in Phase 2
  • Researchers Urge Genetic Testing for Autosomal Dominant Alport Syndrome
  • Children’s Viral Video Plea to Find Kidney Donor for Mom Has Happy Ending
  • Protein Imbalance Theory Unifies Kidney Diseases, Researcher Argues, But Doesn’t Explain Alport Mutations
  • Reata’s Bardoxolone for Alport Syndrome Granted FDA Orphan Drug Status